Showing 7 products for Cell-Based Assays > Drug Resistance Assays
The HoloMonitor ® live cell imaging system enables long-term non-invasive analysis of cell cultures within your standard incubator. Cell biologists worldwide use PHI’s label-free cell imager to automatically obtain accurate live-cell morphology, migration, and proliferation data as well as multi-well time-lapse videos, down to a single-cell level in real-time.
The HoloMonitor ® live cell imaging system enables long-term non-invasive analysis of cell cultures within your standard incubator. With the latest add-on fluorescence module, cell biologists benefit from minimizing light exposure and reducing photocytotoxicity when automatically obtaining accurate live-cell morphology, migration, proliferation data, and multi-well time-lapse videos down to a single-cell level in real-time.
ARRALYZE Glass Nanowell Arrays feature precisely engineered nanowells in borosilicate glass, created with our patented LIDE technology. Each array contains up to 897 individual wells (0.4 × 0.4 × 0.225mm) with dimpled bottoms for optimal single-cell isolation and analysis.
ARRALYZE 8 Chamber Slide combines standard slide format with advanced nanowell technology, featuring 8 chambers with 127 precisely etched nanowells (0.4 × 0.4 × 0.225mm) per chamber. The borosilicate glass bottom (0.175μm thick under wells) provides superior optical clarity for high-resolution imaging while maintaining an inert environment. Includes 3 fiducials per chamber for easy navigation and precise cell tracking.
The Multidrug Resistance Direct Dye Efflux Assay Kit includes two of the best characterized and most commonly used multidrug resistance ABC transporter substrates, DiOC2(3) and rhodamine 123. The kit enables researchers to directly assess the functional activity of the MDR1, MRP1 and BCRP membrane pumps in living cells under physiologic conditions by directly measuring the relative fluorescence of cell populations that activel…
200 cell lines from our OncoSignature™ library grown in 3D spheroids. Providing more physiologically relevant conditions to screen - giving a better understanding of candidate cancer therapeutics.
